Open Access

BRAFV600E‑induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT

  • Authors:
    • Xuhong Wang
    • Xiaoqin Xu
    • Chen Peng
    • Yanchao Qin
    • Taihu Gao
    • Jiexian Jing
    • Hongcai Zhao
  • View Affiliations

  • Published online on: May 14, 2019     https://doi.org/10.3892/ol.2019.10360
  • Pages: 927-935
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Keratin 19 (KRT19) is a type I cytokeratin that serves an important role in multiple types of cancer; however, little is known regarding its role in thyroid cancer. Therefore, the aim of the current study was to investigate the role of KRT19 in thyroid cancer. Using The Cancer Genome Atlas database, the expression and clinical significance of KRT19 in thyroid cancer tissues were investigated. The effect of KRT19 in thyroid cancer cell lines was also investigated in vitro. The results demonstrated that KRT19 expression was higher in thyroid cancer when compared with normal thyroid tissues, and was associated with lymph node metastasis, tumor stage and tumor‑node‑metastasis stage. Knockdown of KRT19 inhibited the proliferation and migration of thyroid cancer cell lines. In addition, increased KRT19 expression was observed only in tumors harboring the B‑Raf Proto‑Oncogene, Serine/Threonine Kinase (BRAF)V600E mutation, and BRAFV600E overexpression induced KRT19 expression. Furthermore, KRT19 exerted its phenotype via promoting epithelial‑mesenchymal transition (EMT). In conclusion, the results of the current study suggest that BRAFV600E‑induced KRT19 expression may promote thyroid cancer metastasis via EMT.
View Figures
View References

Related Articles

Journal Cover

July-2019
Volume 18 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang X, Xu X, Peng C, Qin Y, Gao T, Jing J and Zhao H: BRAFV600E‑induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT. Oncol Lett 18: 927-935, 2019
APA
Wang, X., Xu, X., Peng, C., Qin, Y., Gao, T., Jing, J., & Zhao, H. (2019). BRAFV600E‑induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT. Oncology Letters, 18, 927-935. https://doi.org/10.3892/ol.2019.10360
MLA
Wang, X., Xu, X., Peng, C., Qin, Y., Gao, T., Jing, J., Zhao, H."BRAFV600E‑induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT". Oncology Letters 18.1 (2019): 927-935.
Chicago
Wang, X., Xu, X., Peng, C., Qin, Y., Gao, T., Jing, J., Zhao, H."BRAFV600E‑induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT". Oncology Letters 18, no. 1 (2019): 927-935. https://doi.org/10.3892/ol.2019.10360